Karyopharm Therapeutics Aktie Analyse
05.07.19 | Karyopharm Therapeutics Buy | H.C. Wainwright & Co. | |
03.12.18 | Karyopharm Therapeutics Buy | B. Riley FBR | |
09.11.18 | Karyopharm Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
24.05.18 | Karyopharm Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
15.11.17 | Karyopharm Therapeutics Buy | H.C. Wainwright & Co. | |
15.09.17 | Karyopharm Therapeutics Outperform | RBC Capital Markets | |
08.09.16 | Karyopharm Therapeutics Buy | H.C. Wainwright & Co. | |
28.06.16 | Karyopharm Therapeutics Outperform | Robert W. Baird & Co. Incorporated | |
Werbung
|
|||
16.03.16 | Karyopharm Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
22.12.15 | Karyopharm Therapeutics Buy | Canaccord Adams | |
12.08.15 | Karyopharm Therapeutics Buy | MLV Capital | |
10.11.14 | Karyopharm Therapeutics Outperform | Oppenheimer & Co. Inc. | |
05.11.14 | Karyopharm Therapeutics Buy | MLV Capital |